Literature DB >> 33683294

Local Cerebral Recombinant Tissue Plasminogen Activator Concentrations During Acute Stroke.

Fabian Essig1, Alexander M Kollikowski2, Wolfgang Müllges1, Guido Stoll1, Karl Georg Haeusler1, Michael K Schuhmann1, Mirko Pham2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33683294      PMCID: PMC7941250          DOI: 10.1001/jamaneurol.2021.0065

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN: 2168-6149            Impact factor:   18.302


× No keyword cloud information.
  5 in total

1.  NLRP3 Inhibition Reduces rt-PA Induced Endothelial Dysfunction under Ischemic Conditions.

Authors:  Maximilian Bellut; Anthony T Raimondi; Axel Haarmann; Lena Zimmermann; Guido Stoll; Michael K Schuhmann
Journal:  Biomedicines       Date:  2022-03-24

2.  Integrated Network Pharmacology and UPLC/Q-TOF-MS Screen System to Exploring Anti-Inflammatory Active Components and Mechanism of Shunaoxin Pills.

Authors:  Nianwei Chang; Yu Wang; Min Jiang; Gang Bai
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-14       Impact factor: 2.650

3.  Regulation and Release of Vasoactive Endoglin by Brain Endothelium in Response to Hypoxia/Reoxygenation in Stroke.

Authors:  Axel Haarmann; Lena Zimmermann; Michael Bieber; Christine Silwedel; Guido Stoll; Michael K Schuhmann
Journal:  Int J Mol Sci       Date:  2022-06-25       Impact factor: 6.208

4.  Blockade of Platelet Glycoprotein Ibα Augments Neuroprotection in Orai2-Deficient Mice during Middle Cerebral Artery Occlusion.

Authors:  Michael Bieber; Michael K Schuhmann; Maximilian Bellut; David Stegner; Katrin G Heinze; Mirko Pham; Bernhard Nieswandt; Guido Stoll
Journal:  Int J Mol Sci       Date:  2022-08-22       Impact factor: 6.208

5.  An intravascular perspective on hyper-acute neutrophil, T-cell and platelet responses: Similarities between human and experimental stroke.

Authors:  Guido Stoll; Michael K Schuhmann; Bernhard Nieswandt; Alexander M Kollikowski; Mirko Pham
Journal:  J Cereb Blood Flow Metab       Date:  2022-06-08       Impact factor: 6.960

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.